Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2023 | Cochrane Database of Systematic Reviews |
Apremilast in palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and meta-analysis. | 2023 | Dermatology and Therapy |
Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis | 2023 | Frontiers in Immunology |
The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials | 2023 | Frontiers in Medicine |
Time to relapse after discontinuing systemic treatment for psoriasis: a systematic review. | 2022 | American Journal of Clinical Dermatology |
Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year. | 2022 | Journal of Dermatological Treatment |
Biologics and small molecule inhibitors for treating hidradenitis suppurativa: a systematic review and meta-analysis. | 2022 | Biomedicines |
Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature. | 2022 | Dermatology Practical & Conceptual |
Combination therapy with apremilast and biologics for psoriasis: a systematic review. | 2022 | American Journal of Clinical Dermatology |
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors. | 2022 | Journal of the European Academy of Dermatology & Venereology |
Efficacy and safety of apremilast monotherapy in moderate-to-severe plaque psoriasis: a systematic review and meta-analysis. | 2022 | Dermatologic Therapy |
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: a systematic review and meta-analysis. | 2022 | Modern Rheumatology |
Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. | 2022 | Frontiers in immunology |
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis. | 2021 | Journal of the European Academy of Dermatology and Venereology |
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis. | 2020 | Orphanet Journal of Rare Diseases |
Comparability of European League Against Rheumatology-recommended pharmacological treatments of oral ulcers associated with Behçet’s disease: a systematic literature review of randomized controlled trials. | 2020 | Open Access Rheumatology: Research and Reviews |
Biologics and small molecules in patients with scalp psoriasis: a systematic review. | 2020 | Journal of Dermatological Treatment |
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis. | 2020 | Rheumatic & Musculoskeletal Diseases Open |
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. | 2020 | Rheumatology Advances in Practice |
Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis. | 2019 | Seminars in Arthritis and Rheumatism |
Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals. | 2019 | Rheumatology International |
Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. | 2019 | Journal of the European Academy of Dermatology and Venereology |
Comparison of the efficacy and safety of tofacitinib and apremilast in patients with active psoriatic arthritis: a Bayesian network meta-analysis of randomized controlled trials. | 2019 | Clinical Drug Investigation |
Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis. | 2019 | Seminars in Arthritis and Rheumatism |